tiprankstipranks
Klaria Pharma Holding AB (SE:KLAR)
:KLAR
Sweden Market
KLAR
Klaria Pharma Holding AB
RESEARCH TOOLSreports

Klaria Pharma Holding AB (KLAR) Income Statement

8 Followers

Klaria Pharma Holding AB Income Statement

Last quarter (Q4 2025), Klaria Pharma Holding AB's total revenue was kr-27.00K, a decrease of -102.53% from the same quarter last year. In Q4, Klaria Pharma Holding AB's net income was kr-8.46M. See Klaria Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 9.00Mkr 2.25Mkr 8.45Mkr 5.87Mkr 6.11M
Gross Profit
kr 8.98Mkr 2.25Mkr 8.45Mkr 5.87Mkr -4.85M
Operating Expenses
kr 34.21Mkr 33.45Mkr 40.30Mkr 61.31Mkr 80.97M
Depreciation and Amortization
kr 11.22Mkr 11.22Mkr 11.04Mkr 11.03Mkr 10.96M
EBITDA
kr -14.02Mkr -19.99Mkr -20.81Mkr -44.80Mkr -39.41M
Operating Income
kr -25.24Mkr -31.21Mkr -31.85Mkr -54.97Mkr -50.11M
Other Income/Expenses
kr -13.65Mkr -16.52Mkr -3.76Mkr -8.68Mkr -3.44M
Pretax Income
kr -38.89Mkr -47.73Mkr -35.84Mkr -63.66Mkr -53.55M
Net Income
kr -38.90Mkr -47.75Mkr -35.78Mkr -63.77Mkr -53.53M
Per Share Metrics
Basic EPS
kr -0.21kr -0.38kr -0.36kr -1.10kr -0.97
Diluted EPS
kr -0.21kr -0.38kr -0.36kr -1.10kr -0.97
Weighted Average Shares Outstanding
 185.24M 124.62M 99.40M 58.10M 55.25M
Weighted Average Shares Outstanding (Diluted)
 185.24M 124.62M 100.80M 58.10M 55.25M
Currency in SEK

Klaria Pharma Holding AB Earnings and Revenue History